Publinova

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

product

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies


Thema's



Publicatiedatum
Type
Document
Gebruiksrecht
Alle rechten voorbehouden
Alle rechten voorbehouden
Toegangsrecht
OpenAccess
DOI
Niet bekend
Citeer dit product (APA)